Eden Health has closed $25 million in a Series B funding round led by Flare Capital Partners. Stone Point Capital principals also joined as new investors, while prior backers Greycroft, PJC, Max Ventures and Aspect Ventures took part as well.
Eden Health is a direct-to-employer healthcare provider that specializes in virtual primary care, insurance navigation and workplace pop-up clinics. The New York company notes that it has seen a 500% increase in interest from employers and commercial property owners since the start of COVID-19, and is now offering a back-to-work screening and testing offering. It did not specify how the new funds would be employed.
"What employers are realizing is that they have a responsibility to manage their entire workforce's physical and emotional health," Matt McCambridge, CEO and cofounder of Eden Health, said in a statement. "The optimal management of workforce health meets that individual and their family member where they are, whether it's at their worksite, at home, or in the community. With today's funding and the advances we've developed, we're set to radically improve care delivery and health outcomes."
Bodyport, the maker of a connected bathroom scale for monitoring cardiac biomarkers in the home, has wrapped up an $11.2 million Series A raise led by Boehringer Ingelheim Venture Fund. Playground Global, Initialized Capital and other unnamed backers also participated in the round, which brings the startup's total raise to $15.8 million.
Bodyport said that the raise will be used to "deepen key health partnerships," as well as to kick off a remote monitoring-based "virtual cardiac clinic." News of the raise also came with word on a new collaboration between the startup and Brigham and Women's Hospital that will be focused on early cardiovascular disease detection and the prevention of avoidable hospitalizations.
“Despite the fact that cardiovascular disease is largely preventable, it remains the leading global cause of death,” Corey Centen, CEO and cofounder of Bodyport, said in a statement. “We’re focused on changing the way patients and care teams manage heart disease. By shifting the technology patients can access from a clinical setting to their own home, we are aiming to predict changes in health status before a hospital visit becomes necessary. Ultimately, this early detection could help push care delivery away from its reactive model, reducing costs and drastically improving the quality of life for patients dealing with chronic disease.”
Reify Health, a Boston-based company specializing in cloud-based clinical trial software, has raised $30 million in Series B funding. Battery Ventures headed the round, which also included prior backers Sierra Ventures and Asset Management Ventures.
The startup's StudyTeam platform looks to speed up clinical trial enrollment and reduce workload burdens by handling redundant processes and highlighting data-driven insights. The company said that the technology has so far been used by 1,800 research sites across 26 countries.
With the new funds, the company will continue to expand its platform.
“We see tremendous opportunity for Reify Health to transform the life sciences industry and are thrilled to partner with them to bring life-saving drugs to patients faster,” Neeraj Agrawal, general partner at Battery Ventures, said in a statement.
Encino, California-based mPulse Mobile has raised "more than $16 million" in Series C funding. The Optum Ventures-led round included contributions from existing investors such as HLM Venture Partners, OCA Ventures, SJF Ventures, Echo Health Ventures and Rincon Ventures.
The company uses AI to automate conversations between consumers and healthcare organizations. mPulse Mobile says it has provided the technology to more than 100 healthcare organizations in its lifetime, and that it supports more than 300 million conversations per year.
“This new investment recognizes that scale and solution performance are key factors in successfully engaging consumers in their healthcare, and we will use it to expand our consumer conversational AI capabilities, enhance our client engagement analytics platform and expand our engagement solutions across healthcare verticals,” CEO Chris Nicholson said in a statement.
Retina-AI Health, a startup developing screening software for diabetic retinopathy detection, has raised $5.2 million in Series A funding from private investors and Shipt founder Bill Smith. With this, CEO Dr. Stephen Odaibo said that it would be pushing its product through FDA regulatory approval.
"The confluence of value-based healthcare delivery and artificial intelligence provides a tangible and timely opportunity for positive impact," he said in a statement.
Milwaukee-based healthcare payments and revenue cycle management startup Sift Healthcare has brought in $2.8 million in funding, $1.875 of which is new equity from Rock River Capital Partners, Winnebago Seed Fund and other investors.
Sift said these funds will help build out its data science and data engineering teams as it looks to meet new demands for its AI tools.
"We are honored to have committed investors who recognize the timely opportunity to innovate in the healthcare payments space," Justin Nicols, founder and CEO of Sift, said in a statement. "I am particularly proud that our investors are Wisconsin-based and committed to growing tech companies within our state."
Clearstep Health, maker of an AI care-navigation tool for in-person or virtual care, has collected $1.3 million in pre-seed funding. RRE Ventures, Newark Venture Partners and OCA Ventures all participated.
Noting new use of its technology as a COVID-19 screener with Hartford HealthCare and BayCare Health, the company said that it will be making new hires to support product development and business development.
“The realities of the last few months have reinvigorated us to pursue radical change in healthcare," Adeel Malik, CEO and cofounder of Clearstep, said in a statement. "In light of the challenges the pandemic has surfaced, we’ve seen new and widespread recognition by healthcare organizations of the value in novel care navigation solutions like Clearstep. Our team is tremendously excited to continue transforming how consumers are able find and access the right care, and [we] are thrilled to further accelerate our progress with the backing of such great investors.”